A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol(®) in Patients with Recurrent Platinum-Resistant Ovarian Cancer.
- DOI
- 10.3390/curroncol32100532
- Published
- 2025 Sep 24
- Container
- Current oncology (Toronto, Ont.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/curroncol32100532,
title = {A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol(®) in Patients with Recurrent Platinum-Resistant Ovarian Cancer.},
author = {Holloway RW and Temkin SM and Gordon SW and Gupta S and Jada SR and Ahmad S and McGuire WP},
year = {2025},
journal = {Current oncology (Toronto, Ont.)},
doi = {10.3390/curroncol32100532},
url = {https://doi.org/10.3390/curroncol32100532}
}RIS
TY - JOUR TI - A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol(®) in Patients with Recurrent Platinum-Resistant Ovarian Cancer. AU - Holloway RW AU - Temkin SM AU - Gordon SW AU - Gupta S AU - Jada SR AU - Ahmad S AU - McGuire WP PY - 2025 JO - Current oncology (Toronto, Ont.) DO - 10.3390/curroncol32100532 UR - https://doi.org/10.3390/curroncol32100532 ER -
APA
RW, H., SM, T., SW, G., S, G., SR, J., S, A., & WP, M. (2025). A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol(®) in Patients with Recurrent Platinum-Resistant Ovarian Cancer.. Current oncology (Toronto, Ont.). https://doi.org/10.3390/curroncol32100532
Source records
- pubmed · retrieved 2026-09-25T06:21:49.795Z